Adler Martin W, Rogers Thomas J
Center for Substance Abuse Research, Department of Pharmacology, Temple University School of Medicine, 3400 N. Broad Street, Philadelphia, PA 19140, USA.
J Leukoc Biol. 2005 Dec;78(6):1204-9. doi: 10.1189/jlb.0405222. Epub 2005 Oct 4.
Chemokines are a family of small proteins involved in cellular migration and intercellular communication. Although the chemokines and their receptors are located throughout the brain, they are not distributed uniformly. Among the chemokines and their receptors that are arrayed disproportionately in glia and neurons are monocyte chemotactic protein-1/CC chemokine ligand 2 (CCL2), stromal cell-derived factor-1/CXC chemokine ligand 12 (CXCL12), fractalkine/CX3C chemokine ligand 1, interferon-gamma-inducible-protein-10/CXCL10, macrophage inflammatory protein-1alpha/CCL3, and regulated on activation, normal T cell expressed and secreted/CCL5. In the brain, they are found in the hypothalamus, nucleus accumbens, limbic system, hippocampus, thalamus, cortex, and cerebellum. The uneven distribution suggests that there may be functional roles for the chemokine "system," comprised of chemokine ligands and their receptors. In addition to anatomical, immunohistochemical, and in vitro studies establishing the expression of the chemokine ligands and receptors, there is an increasing body of research that suggests that the chemokine system plays a crucial role in brain development and function. Our data indicate that the chemokine system can alter the actions of neuronally active pharmacological agents including the opioids and cannabinoids. Combined with evidence that the chemokine system in the brain interacts with neurotransmitter systems, we propose the following hypothesis: The endogenous chemokine system in the brain acts in concert with the neurotransmitter and neuropeptide systems to govern brain function. The chemokine system can thus be thought of as the third major transmitter system in the brain.
趋化因子是一族参与细胞迁移和细胞间通讯的小蛋白。尽管趋化因子及其受体遍布整个大脑,但它们并非均匀分布。在胶质细胞和神经元中分布不均衡的趋化因子及其受体包括单核细胞趋化蛋白-1/CC趋化因子配体2(CCL2)、基质细胞衍生因子-1/CXC趋化因子配体12(CXCL12)、分形素/CX3C趋化因子配体1、干扰素-γ诱导蛋白-10/CXCL10、巨噬细胞炎性蛋白-1α/CCL3以及活化正常T细胞表达和分泌因子/CCL5。在大脑中,它们存在于下丘脑、伏隔核、边缘系统、海马体、丘脑、皮质和小脑中。这种分布不均表明由趋化因子配体及其受体组成的趋化因子“系统”可能具有功能作用。除了通过解剖学、免疫组织化学和体外研究确定趋化因子配体和受体的表达外,越来越多的研究表明趋化因子系统在大脑发育和功能中起着关键作用。我们的数据表明,趋化因子系统可以改变包括阿片类药物和大麻素在内的神经活性药物的作用。结合大脑中趋化因子系统与神经递质系统相互作用的证据,我们提出以下假设:大脑中的内源性趋化因子系统与神经递质和神经肽系统协同作用以调控大脑功能。因此,趋化因子系统可被视为大脑中的第三个主要递质系统。